Goodman Noah 4
4 · Kymera Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Goodman Noah
Chief Business Officer
Transactions
- Award
Common Stock
[F1]2026-03-02+9,225→ 59,306.438 total - Award
Stock Option (Right to Buy)
[F2]2026-03-02+18,450→ 18,450 totalExercise: $90.10Exp: 2036-03-01→ Common Stock (18,450 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.
- [F2]The shares underlying this stock option shall vest in fourty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact|2026-03-04